Add Company
Join Now

XyloCor Therapeutics Revenue and Competitors

License our Company Data API

Location

$122M

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • XyloCor Therapeutics's estimated annual revenue is currently $1.1M per year.(i)
  • XyloCor Therapeutics's estimated revenue per employee is $78,686
  • XyloCor Therapeutics's total funding is $122M.

Employee Data

  • XyloCor Therapeutics has 14 Employees.(i)
  • XyloCor Therapeutics grew their employee count by -7% last year.

XyloCor Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
SVP Technology, Manufacturing & QualityReveal Email/Phone
5
VP Clinical OperationsReveal Email/Phone
6
Chief Technology Officer and Head Technical OperationsReveal Email/Phone
7
Finance / FP&AReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M5714%N/AN/A
#2
$205.9M158919%N/AN/A
#3
$52.4M4116%N/AN/A
#4
$21.7M1938%N/AN/A
#5
$5.5M55-2%N/AN/A
#6
$5.1M50-4%N/AN/A
#7
$1.1M2335%N/AN/A
#8
$0.3M50%N/AN/A
#9
$0.1M20%N/AN/A
#10
$2.7M323%N/AN/A
Add Company

What Is XyloCor Therapeutics?

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

keywords:N/A

$122M

Total Funding

14

Number of Employees

$1.1M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

XyloCor Therapeutics News

2022-04-06 - Gene Therapies & Associated Vectors 2022: Intellectual ...

DUBLIN, April 13, 2022 /PRNewswire/ -- The "Gene Therapies ... Wellstat Biologics; Xenetic Biosciences; XyloCor Therapeutics; Zycos.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M14-12%N/A
#2
$1.3M157%N/A
#3
$2.1M1614%N/A
#4
$2M1633%N/A
#5
N/A186%N/A